| Islam M Elfayoumi, MD | |
|
350 Boulevard, Passaic, NJ 07055-2840 | |
| (973) 365-4000 | |
| Not Available |
| Full Name | Islam M Elfayoumi |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 21 Years |
| Location | 350 Boulevard, Passaic, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063450591 | NPI | - | NPPES |
| 0197769 | Medicaid | NJ | |
| 275330800 | Medicaid | FL | |
| 52550 | Other | FL | BCBS |
| P00471993 | Other | FL | RR MEDICARE |
| P00765998 | Other | PA | RR MEDICARE |
| P00829446 | Other | NJ | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | ME95068 (Florida) | Secondary |
| 207R00000X | Internal Medicine | 25MA08506700 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Holy Name Medical Center | Teaneck, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| House Physician Partners Pc | 7517944366 | 21 |
News Archive
Powerful drugs used to treat patients with rheumatoid arthritis have a profound, previously unrecognized effect on the immune system, breaking up molecular "training camps" for rogue cells that play an increasingly recognized role in autoimmune diseases like rheumatoid arthritis and lupus.
Researchers have developed a new AI-driven platform that can analyze how pathogens infect our cells with the precision of a trained biologist.
In the study, published on the pre-print server medRxiv*, the researchers found a slight but significantly elevated risk of SARS-CoV-2 infection in households with young children between 10 months and five years old. However, recent exposure to human coronaviruses does not reduce the risk of SARS-CoV-2 infection in households with young children.
UCSF prevention experts have released the Positive Prevention Toolkit, a collection of resources designed to enable HIV/AIDS caregivers to provide prevention messages when interacting with HIV-positive patients. The goal is to help patients modify their behavior to reduce risk and decrease the spread of HIV.
Nymox Pharmaceutical Corporation is pleased to report positive new results from the 30-36 month follow-up study of patients treated with NX-1207 in Study NX02-0016. The initial study, completed in the U.S. in 2007, reached statistical significance in Intent-to-Treat Primary Efficacy outcomes at 90 days and 6 months post-treatment with NX-1207 2.5 mg.
› Verified 4 days ago
| Entity Name | House Physician Partners Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457377806 PECOS PAC ID: 7517944366 Enrollment ID: O20040630000748 |
News Archive
Powerful drugs used to treat patients with rheumatoid arthritis have a profound, previously unrecognized effect on the immune system, breaking up molecular "training camps" for rogue cells that play an increasingly recognized role in autoimmune diseases like rheumatoid arthritis and lupus.
Researchers have developed a new AI-driven platform that can analyze how pathogens infect our cells with the precision of a trained biologist.
In the study, published on the pre-print server medRxiv*, the researchers found a slight but significantly elevated risk of SARS-CoV-2 infection in households with young children between 10 months and five years old. However, recent exposure to human coronaviruses does not reduce the risk of SARS-CoV-2 infection in households with young children.
UCSF prevention experts have released the Positive Prevention Toolkit, a collection of resources designed to enable HIV/AIDS caregivers to provide prevention messages when interacting with HIV-positive patients. The goal is to help patients modify their behavior to reduce risk and decrease the spread of HIV.
Nymox Pharmaceutical Corporation is pleased to report positive new results from the 30-36 month follow-up study of patients treated with NX-1207 in Study NX02-0016. The initial study, completed in the U.S. in 2007, reached statistical significance in Intent-to-Treat Primary Efficacy outcomes at 90 days and 6 months post-treatment with NX-1207 2.5 mg.
› Verified 4 days ago
| Entity Name | Optum Medical Care Of New Jersey Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578665048 PECOS PAC ID: 3072650290 Enrollment ID: O20091021000129 |
News Archive
Powerful drugs used to treat patients with rheumatoid arthritis have a profound, previously unrecognized effect on the immune system, breaking up molecular "training camps" for rogue cells that play an increasingly recognized role in autoimmune diseases like rheumatoid arthritis and lupus.
Researchers have developed a new AI-driven platform that can analyze how pathogens infect our cells with the precision of a trained biologist.
In the study, published on the pre-print server medRxiv*, the researchers found a slight but significantly elevated risk of SARS-CoV-2 infection in households with young children between 10 months and five years old. However, recent exposure to human coronaviruses does not reduce the risk of SARS-CoV-2 infection in households with young children.
UCSF prevention experts have released the Positive Prevention Toolkit, a collection of resources designed to enable HIV/AIDS caregivers to provide prevention messages when interacting with HIV-positive patients. The goal is to help patients modify their behavior to reduce risk and decrease the spread of HIV.
Nymox Pharmaceutical Corporation is pleased to report positive new results from the 30-36 month follow-up study of patients treated with NX-1207 in Study NX02-0016. The initial study, completed in the U.S. in 2007, reached statistical significance in Intent-to-Treat Primary Efficacy outcomes at 90 days and 6 months post-treatment with NX-1207 2.5 mg.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Islam M Elfayoumi, MD 405 Lincoln St, Carlstadt, NJ 07072-1414 Ph: (732) 986-4965 | Islam M Elfayoumi, MD 350 Boulevard, Passaic, NJ 07055-2840 Ph: (973) 365-4000 |
News Archive
Powerful drugs used to treat patients with rheumatoid arthritis have a profound, previously unrecognized effect on the immune system, breaking up molecular "training camps" for rogue cells that play an increasingly recognized role in autoimmune diseases like rheumatoid arthritis and lupus.
Researchers have developed a new AI-driven platform that can analyze how pathogens infect our cells with the precision of a trained biologist.
In the study, published on the pre-print server medRxiv*, the researchers found a slight but significantly elevated risk of SARS-CoV-2 infection in households with young children between 10 months and five years old. However, recent exposure to human coronaviruses does not reduce the risk of SARS-CoV-2 infection in households with young children.
UCSF prevention experts have released the Positive Prevention Toolkit, a collection of resources designed to enable HIV/AIDS caregivers to provide prevention messages when interacting with HIV-positive patients. The goal is to help patients modify their behavior to reduce risk and decrease the spread of HIV.
Nymox Pharmaceutical Corporation is pleased to report positive new results from the 30-36 month follow-up study of patients treated with NX-1207 in Study NX02-0016. The initial study, completed in the U.S. in 2007, reached statistical significance in Intent-to-Treat Primary Efficacy outcomes at 90 days and 6 months post-treatment with NX-1207 2.5 mg.
› Verified 4 days ago
Mr. Ryan Murray, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 80 Passaic Ave, Passaic, NJ 07055 Phone: 973-928-2167 | |
Dr. Kunal Brahmbhatt, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 293 Passaic St, Passaic, NJ 07055 Phone: 973-916-0002 Fax: 973-916-0027 | |
Hayat Lakluk, Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 350 Boulevard, Passaic, NJ 07055 Phone: 973-365-4300 | |
Hitesh Raheja, Internal Medicine Medicare: Medicare Enrolled Practice Location: 293 Passaic St, Passaic, NJ 07055 Phone: 973-916-0002 Fax: 973-916-0027 | |
Dr. Sheue H. Lee, MD Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 350 Boulevard, Passaic, NJ 07055 Phone: 973-365-4554 Fax: 973-574-2355 | |
Marvin Tillman Boyd, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 350 Boulvard The Boyd Renal Clinic, St. Mary's Hospital Ambulatory Services,, Passaic, NJ 07055 Phone: 973-594-7800 Fax: 973-594-7801 |